Search Videos and More
Cracking Glioblastoma’s Deadly Code: Research Focused on Improving Diagnosis and Genomics to Revolutionize Care
Even with growing awareness of the devastating effects of glioblastoma, the most common and aggressive form of brain cancer, treatment options remain limited and patients typically survive just 15-18 months beyond diagnosis. Researchers at the Miami Cancer Institute and Miami Neuroscience Institute, part of Baptist Health South Florida, are focusing their efforts to advance understanding of the disease and improve diagnostic, prognostic, and therapeutic outcomes.Baptist Health’s High-Tech High-Touch Approach - Live Webcast on Breast Health
Originally Broadcast: Wednesday, May 31, 2023 | 5:30-6:30pm ET Join Baptist Health experts for a webinar focused on breast health; beginning with imaging through the continuum of care at Miami Cancer Institute.Advances in Repairing or Replacing Heart Valves Continue at a Steady Pace at Baptist Health Miami Cardiac & Vascular Institute
Pivotal advances in treating or replacing heart valves, many of them initiated as part of national clinical trials, have taken place at Baptist Health Miami Cardiac & Vascular Institute over the past two decades. And they continue at a very steady pace.Speaking from the Hip: A Discussion on Orthopedic Care, Episode Two
Orthopedic Surgeons John Uribe, M.D. and Anthony Miniaci, M.D., Chief Medical Executive and Deputy Chief Medical Executive respectively, sit down and talk all things Orthopedic Care on this episode of Speaking from the Hip, brought to you by Baptist Health Orthopedic Care.Diego Torres-Russotto, M.D., joins Baptist Health Miami Neuroscience Institute as Chair of Neurology
Diego Torres-Russotto, M.D., joins Baptist Health Miami Neuroscience Institute, as the inaugural chair of the Neurology division.Baptist Health Orthopedic Care Offers Latest Robotic-Assisted System for Minimally Invasive Hip, Knee Replacements
The manufacturer of the ROSA Hip System, the latest advancement in surgical robotics, states that it is “precisely personalized” by providing surgeons with real-time data and imaging feedback on the patient’s unique hip anatomy.Lutetium-177 (177Lu) - PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Updated National Society Guidelines
The most recent American Society of Clinical Oncology (ASCO) guidelines for the management of metastatic castration-resistant prostate cancer (mCRPC) was published in 2014.AI: A Game-Changer in Screening Mammography
Diagnostic radiologists can scroll through upwards of 25,000 mammography images per day in search of the smallest suspicious lesion. The task is extremely taxing and image interpretation is variable.Milestone 1000th Patient Treated Using Gamma Knife at Miami Cancer Institute
Leading the fight against brain metastases, Baptist Health Miami Cancer Institute hit a new milestone recently. The center treated its 1000th patient using Gamma Knife radiosurgery, an incisionless radiation therapy that precisely targets a tumor, importantly minimizing damage to otherwise healthy brain tissue.New Class of Drugs Show Promise in Treating Recurrent Cervical Cancer
With a poor prognosis for many patients with relapsing gynecological cancers ? particularly for those who received conventional treatment only ? gynecological oncologists are on the search for novel therapies.With a Focus on Advancing Cancer Treatments, Researchers With Baptist Health Cancer Care Focus on Trials Benefiting Patients
From a deep dive into genetic mutations to studies using novel therapies, physician-investigators at Miami Cancer Institute and Lynn Cancer Institute, part of Baptist Health Cancer Care, are conducting important leading edge research to advance cancer care.Preventing Fractures in the Bone Mets Population
Preventing fractures in patients with bone metastasis improves mobility and quality of life ? and for some, it means prolonged survival as well, according to recent studies. While not all cancer patients have access to an orthopedic oncologic specialist, it’s important that medical and radiation oncologists prioritize the referral of those with bone mets for a skeletal evaluation early in their diagnosis, says Juan Pretell, M.D., chief of musculoskeletal oncology surgery at Baptist Health Miami Cancer Institute.